PTC Therapeutics
PTCT
#3047
Rank
$5.30 B
Marketcap
$63.49
Share price
0.21%
Change (1 day)
-15.68%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -$85.09 Million USD

According to PTC Therapeutics 's latest financial reports the company's current earnings are $1.15 Billion USD. In 2025 the company made an earning of $0.69 Billion USD, an increase over its 2024 earnings that were of -$0.37 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$85.09 Million-112.21%
2025 $0.69 B-291.84%
2024 -$0.37 Billion-47.84%
2023 -$0.7 Billion18.49%
2022 -$0.59 Billion13.34%
2021 -$0.52 Billion28.64%
2020 -$0.41 Billion67.94%
2019 -$0.24 Billion87.28%
2018 -$0.13 Billion64.95%
2017 -$77.67 Million-45.13%
2016 -$0.15 Billion-16.72%
2015 -$0.17 Billion72.64%
2014 -$98.45 Million90.89%
2013 -$51.58 Million96.58%
2012 -$26.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
$12.64 B-14,958.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
$4.56 B-5,460.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-$0.12 Billion 35.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-$0.14 Billion 53.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-$0.14 Billion 57.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-$0.69 Billion 704.62%๐Ÿ‡บ๐Ÿ‡ธ USA